Go To Global Site
Welcome to UCB in the United States

May

15

UCB Statement on COVID-19 Outbreak

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.

May

12

Recognizing the Many Forms of Arthritis this Arthritis Awareness Month

UCB is passionate about transforming the lives of people living with severe diseases and uncovering the intersections of scientific understanding and patient needs. This May, we are honoring Arthritis Awareness Month and Spondyloarthritis Awareness Month by exploring the impacts of different kinds of arthritis on patients. Learn more about psoriatic arthritis, rheumatoid arthritis, and non-radiographic axial spondyloarthritis, their prevalence, and how individuals living with these diseases are impacted.

May

08

Disease Spotlight: Psoriatic Arthritis

Developing impactful and innovative solutions for patients whose lives have been challenged by severe diseases is our focus at UCB. This Arthritis Awareness Month, learn more about psoriatic arthritis (PsA), one of the many types of arthritic disease.

Apr

24

UCB Volunteers Help Communities Impacted by COVID-19

Serving others is in our DNA at UCB – from committing to patients in our daily jobs to finding ways to make a difference in our communities through volunteerism. Each year, UCB employees get 32-hours of time off to volunteer their time at non-profits of their choice, and COVID-19 has not slowed us down from using those hours to help others during this difficult time. This National Volunteer Week, we’re celebrating our employees, whose selfless efforts during this COVID-19 pandemic inspire us.

Apr

22

Minimizing Our Environmental Footprint

During the COVID-19 pandemic, we’re reminded of the many challenges facing our world. At UCB, we recognize the challenges facing the world, from climate change to rising inequalities, are inextricably linked and that businesses have a key role to play to ensure a sustainable future for all. This Earth Day, we’re highlighting some of our progress as it relates to minimizing our environmental footprint across the value chain.

Apr

17

Celebrating Warriors with Parkinson’s Disease

Today, across the globe, people are being impacted by COVID-19, causing not only illness, but also uncertainty and fear. With April being Parkinson’s Awareness month, we're sharing the inspirational stories of PD Warriors who are breaking barriers despite their diagnosis to spread a little positivity during this challenging time. These warriors recently shared their stories with More Than Motion, UCB’s community dedicated to raising awareness of the realities of living with Parkinson's disease (PD), and we're honored to feature them this month.

Apr

10

UCB’s Three-Point Plan to Help Combat COVID-19 in the U.S.

With the U.S. heavily impacted by the novel coronavirus, COVID-19, UCB is committed to playing our part to contribute our scientific expertise and resources to the greater response effort happening across the country and the world. This includes expanding our assistance programs to further help patients impacted by the pandemic.

Apr

02

UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients

UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients.

Mar

10

UCB Supports Indiana University Research on Epilepsy Emergency Room Educational Materials

The emergency department is a common point of medical intervention for epilepsy patients. We recognize there are more than one million visits to the emergency department every year for epilepsy-related seizures . These visits are not only a significant cost to the healthcare system, but also often leave patients with questions and unease related to their epilepsy diagnosis. The Centers for Disease Control and Prevention (CDC) has also recognized epilepsy as a public health challenge where patients need more skills and resources to manage their condition effectively. That’s why UCB Inc. is working with Indiana University School of Nursing to address existing gaps in care when it comes to emergency department visits and epilepsy care.

Mar

02

Diversity in Clinical Trials: UCB’s Approach

Diversity and inclusion in clinical trials is critical, and UCB is working to find new ways to connect to unique patient populations through our technological and data driven approaches. Kim Doggett, Head of Site Engagement, and her team focus on how they can provide value to patients by finding new ways to build relationships with clinical investigative sites to ensure we are reaching the targeted patient populations where we hope to provide meaningful solutions. Read more from Kim as she shares UCB’s diversity and inclusion approach to clinical trials.